ALEXZA PHARMS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEXZA PHARMS, and when can generic versions of ALEXZA PHARMS drugs launch?
ALEXZA PHARMS has one approved drug.
There are five US patents protecting ALEXZA PHARMS drugs.
There are two hundred and twenty patent family members on ALEXZA PHARMS drugs in twenty-one countries and ten supplementary protection certificates in eight countries.
Summary for ALEXZA PHARMS
| International Patents: | 220 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for ALEXZA PHARMS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 7,537,009 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 9,370,629 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 7,458,374 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALEXZA PHARMS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 8,173,107 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 9,687,487 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 9,370,629 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALEXZA PHARMS Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 158955 | ⤷ Subscribe |
| European Patent Office | 1389097 | ⤷ Subscribe |
| Japan | 2006514633 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ALEXZA PHARMS Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1389098 | C01389098/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: LOXAPINUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65461 13.12.2016 |
| 1389098 | 473 | Finland | ⤷ Subscribe | |
| 1389098 | 2013C/054 | Belgium | ⤷ Subscribe | PRODUCT NAME: LOXAPINE; AUTHORISATION NUMBER AND DATE: EU/1/13/823/001 20130225 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
